Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 34Recruiting 7Unknown 6Terminated 6Active not recruiting 6Withdrawn 2Not yet recruiting 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neuroblastoma 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Etoposide 3Drug Therapy 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2cemiplimab 2Vincristine 2Temozolomide 2Platinum 2Paclitaxel 2Injections 2Immunotherapy, Adoptive 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Docetaxel 2Carboplatin 2Capecitabine 2Bevacizumab 2venetoclax 1relmacabtagene autoleucel 1pomalidomide 1pirtobrutinib 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × fludarabine phosphate × Clear all
NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡